News summary

Menopause guideline update: ACOG strongly backs hormone therapy for hot flushes

Source: Longevity Docs News • Published: 22 Oct 2026, 00:00

Summarized by Masters of Longevity from Longevity Docs News.

Menopausal care guidance: what clinicians need from an updated practice guideline on treating hot flushes, sleep, and mood symptoms.

Menopause guideline update: ACOG strongly backs hormone therapy for hot flushes
Key Takeaways
  • ACOG strongly recommends systemic menopausal hormone therapy for vasomotor symptoms and related sleep disturbance in patients without contraindications when started before age 60 or within ten years of natural menopause.
  • Randomized trials show hormone therapy reduces hot flush frequency by about 57% and severity by about 71%, with transdermal estradiol plus progestogen ranked most effective.
  • For patients who cannot or will not take hormones, SSRIs/SNRIs and neurokinin receptor antagonists are strongly recommended, while behavioral therapies and gabapentin are considered conditional options.
Read the full article at Longevity Docs News ↗

Continue exploring

Recommended MoL Picks

MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.